| Authors: |
Korompis M; The Jenner Institute, University of Oxford, Oxford, UK., De Voss CJ; The Jenner Institute, University of Oxford, Oxford, UK., Li S; The Jenner Institute, University of Oxford, Oxford, UK., Richard A; The Jenner Institute, University of Oxford, Oxford, UK., Almujri SS; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Pharmacology, College of Pharmacy, King Khalid University, 61421, Asir-Abha, Saudi Arabia., Ateere A; The Jenner Institute, University of Oxford, Oxford, UK., Frank G; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228, Plan-les-Ouates, Switzerland., Lemoine C; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228, Plan-les-Ouates, Switzerland., McShane H; The Jenner Institute, University of Oxford, Oxford, UK., Stylianou E; The Jenner Institute, University of Oxford, Oxford, UK. elena.stylianou@ndm.ox.ac.uk. |
